Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial

IMPORTANCE: Opioid-stimulant co-use is a common problem with few evidence-based treatments. OBJECTIVE: To examine bupropion slow release (SR) enhancement of a tailored abstinence incentive program for stimulant use in persons with opioid use disorder. DESIGN, SETTING, AND PARTICIPANTS: This 26-week,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ware, Orrin D., Sweeney, Mary M., Cunningham, Colin, Umbricht, Annie, Stitzer, Maxine, Dunn, Kelly E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018324/
https://www.ncbi.nlm.nih.gov/pubmed/36920397
http://dx.doi.org/10.1001/jamanetworkopen.2023.2278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018324/
https://www.ncbi.nlm.nih.gov/pubmed/36920397
http://dx.doi.org/10.1001/jamanetworkopen.2023.2278

Ejemplares similares